Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 37 results found. Search for [ COVID-19 vaccines required for phase 1 ]

Results 1 to 21 of 37
BusinessToday.In
April 22, 2021
\"All those above the age of 18 can register on CoWin by April 24...the vaccination process and documents remain the same,\" said Chief Executive Officer of the National Health Authority (NHA) RS Sharma


BusinessToday.In
April 21, 2021
Over the past 50 days, 9.78 crore Indians got the first shot of the vaccine, whereas the second dose was administered to a little over 1.5 crore Indians


BusinessToday.In
April 13, 2021
The government has not started with the vaccination of people under the age of 45 yet, but whenever it'll start, another 4 months will be required to cover them at the present rate of vaccination


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
March 1, 2021
All vaccines provided to beneficiaries at the government health facilities will be entirely free of cost, while private facilities cannot charge the beneficiary a sum above Rs 250 per person per dose


BusinessToday.In
February 25, 2021
If you are above 45 and with comorbidities (with one or more diseases), you are eligible to get a Covid-19 jab. However, you'll have to produce a signed medical certificate, showing the severity of your illness


Associated Press
February 20, 2021
Central European authorities warned on Friday that they are witnessing an increase in coronavirus infections across their region amid discovery of new variants


BusinessToday.In
February 1, 2021
Sensex, Nifty Highlights on Budget day, February 1: Almost all the sectors closed in green territory today, rising in the range of 3-6%, except for pharma index


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


BusinessToday.In
January 19, 2021
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Tuesday recommended Bharat Biotech's intranasal vaccine for conducting phase 1 clinical trials for the coronavirus


BusinessToday.In
January 15, 2021
Coronavirus vaccine: The CoWIN app is being populated with the data of 1 crore healthcare workers who would receive the coronavirus vaccine in the first phase. So far only officials have access to it


BusinessToday.In
January 12, 2021
The two vaccines - Covishield and Covaxin - have received regulatory approval after extensive studies. The Covishield  vaccine has already been rolled out in the UK


PTI
January 11, 2021
Several states have made all necessary preparations for the first phase of the exercise comprising identifying vaccination sites and registration of healthcare and other frontline workers


BusinessToday.In
January 8, 2021
The amount is likely to be disbursed on the basis of beneficiary load on the states. This means states with more healthcare workers registered on Co-WIN platform would get more funds


Manoj Sharma | Mudit Kapoor
January 7, 2021
Initial 30 crore vaccinations (60 crore doses) planned by the Centre would have cost Rs 13,200 crore. However, need for 66 crore doses raises the cost by Rs 1320 crore


Manoj Sharma
December 31, 2020
Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves


BusinessToday.In
December 25, 2020
Around 2,360 participants have been trained during the national-level training. The state-level training has been completed in all states/UTs and 7,000 district level trainees got hands-on experience on vaccine handling and distribution


BusinessToday.In
December 19, 2020
The COVID-19 vaccine in India will be first offered to healthcare workers, frontline workers and persons above 50 years of age. Depending on the disease epidemiology and vaccine's availability, the remaining population will be vaccinated later on


Reuters
December 18, 2020
If India received a lower allocation of 95-125 million doses via COVAX, then the cost to the government of procuring additional shots would go up to $1.8 billion


PTI
December 1, 2020
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions


PAGES 1 OF 2  12